191
Heterologous Prime-boost Immunization With an Aerosolised Adenovirus Type-5 Vector-based COVID-19 Vaccine (Ad5-nCoV) After Priming With an Inactivated SARS-CoV-2 Vaccine
Condition(s):COVID-19Last Updated:August 16, 2022Active, not recruiting
SARS-CoV-2: 10468 Clinical Trials, Page 20 of 1047
Hide Studies Not Open or Pending
192
SARS-CoV-2 Vaccine (COH04S1) Versus EUA SARS-COV-2 Vaccine for the Treatment of COVID-19 in Patients With Blood Cancer
Condition(s):COVID-19 Infection; Hematopoietic and Lymphoid System Neoplasm; Leukemia; Lymphoma; Plasma Cell MyelomaLast Updated:April 28, 2023Recruiting
193
Performance Evaluation of RealDetect™ COVID-19 RT-PCR Kit for the Detection of SARS-CoV-2 Virus
Condition(s):High Sensitivity and Specificity (With 95% Confidence Interval) of RealDetect™ COVID-19 RT-PCR KitLast Updated:May 28, 2020Unknown status
194
Process Evaluation of a Residence-Based SARS-CoV-2 Testing Participation Pilot
Condition(s):Covid19Last Updated:September 22, 2021Completed
195
Evaluation of the Immune Response to SARS-CoV-2 Among Patients With Covid-19 in Costa Rica
Condition(s):COVID-19Last Updated:September 3, 2020Unknown status
196
Heterologous Boost Immunization With an Aerosolised Ad5-nCoV After Two-dose Priming With an Inactivated SARS-CoV-2 Vaccine
Condition(s):COVID-19Last Updated:May 17, 2022Active, not recruiting
197
COVID-19 Staff Testing of Antibody Responses Study (Co-Stars)
Condition(s):SARS-CoV-2 InfectionLast Updated:September 27, 2022Completed
198
Clinical Trial to Evaluate the Safety and Immunogenicity of the COVID-19 Vaccine
Condition(s):COVID-19Last Updated:February 18, 2022Completed
199
Study of the Kinetics of COVID-19 Antibodies for 24 Months in Patients With Confirmed SARS-CoV-2 Infection
Condition(s):Covid19; SARS-CoV-2Last Updated:March 20, 2023Completed
200
Serological Study of the Exposure of Personnel to Sars-cov-2
Condition(s):Sars-CoV2Last Updated:June 9, 2020Unknown status